Literature DB >> 25091966

Invasive testing for coronary artery disease: FFR, IVUS, OCT, NIRS.

Elliott M Groves1, Arnold H Seto2, Morton J Kern3.   

Abstract

Coronary angiography is the gold standard for the diagnosis of coronary artery disease and guides revascularization strategies. The emergence of new diagnostic modalities has provided clinicians with adjunctive physiologic and image-based data to help formulate treatment strategies. Fractional flow reserve can predict whether percutaneous intervention will benefit a patient. Intravascular ultrasonography and optical coherence tomography are intracoronary imaging modalities that facilitate the anatomic visualization of the vessel lumen and characterize plaques. Near-infrared spectroscopy can characterize plaque composition and potentially provide valuable prognostic information. This article reviews the indications, basic technology, and supporting clinical studies for these modalities. Published by Elsevier Inc.

Entities:  

Keywords:  Coronary artery disease; Fractional flow reserve; Intravascular ultrasonography; Near-infrared spectroscopy; Optical coherence tomography

Mesh:

Year:  2014        PMID: 25091966     DOI: 10.1016/j.ccl.2014.04.005

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  3 in total

1.  Anomalous Coronary Arteries and Myocardial Bridges: Risk Stratification in Children Using Novel Cardiac Catheterization Techniques.

Authors:  Hitesh Agrawal; Silvana Molossi; Mahboob Alam; S Kristen Sexson-Tejtel; Carlos M Mery; E Dean McKenzie; Charles D Fraser; Athar M Qureshi
Journal:  Pediatr Cardiol       Date:  2017-02-18       Impact factor: 1.655

2.  Intravascular ultrasound observation of the mechanism of no-reflow phenomenon in acute myocardial infarction.

Authors:  Junxia Li; Longmei Wu; Xinli Tian; Jian Zhang; Yujie Shi
Journal:  PLoS One       Date:  2015-06-02       Impact factor: 3.240

Review 3.  Intracoronary Imaging in the Detection of Vulnerable Plaques.

Authors:  Jonathan A Batty; Shristy Subba; Peter Luke; Li Wing Chi Gigi; Hannah Sinclair; Vijay Kunadian
Journal:  Curr Cardiol Rep       Date:  2016-03       Impact factor: 2.931

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.